Aptevo Therapeutics CEO Marvin White's 2021 pay jumps 188% to $2.8M
Aptevo Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 27, 2022
Aptevo Therapeutics reported fiscal year 2021 executive compensation information on April 27, 2022.
In 2021, four executives at Aptevo Therapeutics received on average a compensation package of $1.6M, a 118% increase compared to previous year.
Average pay of disclosed executives at Aptevo Therapeutics
Marvin L. White, Chief Executive Officer, received $2.8M in total, which increased by 188% compared to 2020. 69% of White's compensation, or $1.9M, was in stock awards. White also received $297K in non-equity incentive plan, $565K in salary, as well as $8.7K in other compensation.
Jeffrey G. Lamothe, Chief Financial Officer, received a compensation package of $1.3M, which increased by 114% compared to previous year. 56% of the compensation package, or $737K, was in stock awards.
Jane Gross, Chief Scientific Officer, earned $1.3M in 2021, a 113% increase compared to previous year.
SoYoung Kwon, General Counsel, received $959K in 2021.
Related executives
You may also like
Source: SEC filing on April 27, 2022.